Autonomous Experimentation

Problem class

Manual experimentation limits throughput to human working hours and cognitive bandwidth. Autonomous systems run 24/7, iterate faster, and explore design spaces systematically with less bias.

Mechanism

A Bayesian optimization or active-learning algorithm selects the next experiment based on prior results and an uncertainty model. Robotic liquid handlers, synthesizers, and analytical instruments execute and capture results. The ML model updates predictions and selects the next iteration, closing the design-build-test-learn loop without human intervention between cycles.

Required inputs

• Defined experimental design space and objective function
• Robotic synthesis and analytical instrumentation
• ML experiment planner with prior knowledge encoding
• Safety interlocks and out-of-bounds experiment constraints

Produced outputs

• Optimized experimental conditions with uncertainty bounds
• Automated experimental logs with full provenance data
• Updated ML models trained on each iteration's results
• Recommended next-phase experiments or scale-up conditions

Industries where this is standard

• Pharmaceutical companies optimizing drug formulation and synthesis routes
• Battery and energy-materials companies screening electrolyte compositions
• Specialty chemicals firms optimizing catalysts and reaction conditions
• Biotechnology companies engineering proteins and biological pathways

Counterexamples

• Automating experiments without encoding domain constraints produces hazardous or nonsensical conditions that damage equipment and erode chemist trust in the platform.
• Optimizing a narrow objective function without multi-objective considerations finds locally optimal but practically useless formulations that fail downstream requirements.

Representative implementations

• Berkeley Lab's A-Lab autonomously synthesized 41 novel compounds in 17 days at 71% success rate — over 2 new materials per day versus months traditionally.
• Novartis's MicroCycle platform evaluates 100 unique compounds per cycle versus a handful previously, generating full biochemical and cellular data per compound.
• Merck KGaA's BayBE achieved 4× throughput increase across ~30 use cases including EUV photoresist and OLED chemistry optimization.

Common tooling categories

Robotic liquid-handling systems, Bayesian optimization frameworks, cloud lab orchestration platforms, and automated analytical instruments.